Dr. Damani has been a “change agent” in health care because of his emphasis on more individualized approaches to therapy based on the patient’s genetics, family history, lifestyle, and life goals. In addition to receiving Masters in Clinical Investigation from The Scripps Research Institute, he is one of the nation’s few physicians with a Doctorate in Pharmacy.
He recently directed a National Institutes of Health study on biomarkers of heart attack. This has resulted in several patent applications and spawned collaborations between numerous academic enterprises including Johnson & Johnson, and Scripps Health.
He has written over 40 articles and 3 book chapters on topics related to personalized medicine. He has served as a scientific advisor for the prominent journal – Science Translational Medicine, and continues to serve as a reviewer for Nature Genetics, Annals of Internal Medicine, American Journal of Cardiology, and the Journal of the American College of Cardiology.
In addition to serving as CEO of MD Revolution, Inc., Dr. Damani serves as a Voluntary Clinical Instructor in the Department of Family & Preventive Medicine for the UC San Diego medical school, and is a practicing cardiologist for Scripps Clinic – a top 50 ranked heart hospital by US News and World Report.